Chris Chalk

Assessing the relationship between gout and the metabolic syndrome may provide insight into the management of both conditions.

There are important differences in TNFis for specific clinical conditions that recent research has made more apparent.

Although recent pharmacologic advances have improved disease progression and prognosis in RA, a number of patients experience joint stiffness.

Continued research is needed to guide a clearer understanding of the role infectious agents, anticitrullinated protein antibodies, and antinative protein antibodies play in rheumatoid arthritis autoimmunity.

Only limited data is available regarding the safety of anti-rheumatic drugs in pregnancy.